Anti-leukotrienes for asthma

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The field of cysteinyl leukotriene research has moved forward considerably in the past two years. Significant recent advances have been made in three areas: genetic control of the cysteinyl leukotriene response, in which alterations in both the promoter region and in transcribed mRNA have been described; the mechanisms by which cysteinyl leukotrienes promote the development of inflammation; and extensions in the clinical arena that support broader positioning of leukotriene modifiers in the therapy of asthma and allergic diseases.

Original languageEnglish (US)
Pages (from-to)230-234
Number of pages5
JournalCurrent Opinion in Pharmacology
Volume1
Issue number3
DOIs
StatePublished - Jun 1 2001
Externally publishedYes

Fingerprint

Leukotrienes
Asthma
Genetic Promoter Regions
Inflammation
Messenger RNA
Research
cysteinyl-leukotriene
Therapeutics

Keywords

  • Cysteinyl leukotrienes
  • Eosinophils
  • Genetics
  • Immunology
  • Leukotriene modifiers
  • Molecular Medicine
  • Pharmacology

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Anti-leukotrienes for asthma. / Calhoun, William.

In: Current Opinion in Pharmacology, Vol. 1, No. 3, 01.06.2001, p. 230-234.

Research output: Contribution to journalArticle

@article{72b407dfea884702bd0eaad1b9d05342,
title = "Anti-leukotrienes for asthma",
abstract = "The field of cysteinyl leukotriene research has moved forward considerably in the past two years. Significant recent advances have been made in three areas: genetic control of the cysteinyl leukotriene response, in which alterations in both the promoter region and in transcribed mRNA have been described; the mechanisms by which cysteinyl leukotrienes promote the development of inflammation; and extensions in the clinical arena that support broader positioning of leukotriene modifiers in the therapy of asthma and allergic diseases.",
keywords = "Cysteinyl leukotrienes, Eosinophils, Genetics, Immunology, Leukotriene modifiers, Molecular Medicine, Pharmacology",
author = "William Calhoun",
year = "2001",
month = "6",
day = "1",
doi = "10.1016/S1471-4892(01)00041-8",
language = "English (US)",
volume = "1",
pages = "230--234",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Anti-leukotrienes for asthma

AU - Calhoun, William

PY - 2001/6/1

Y1 - 2001/6/1

N2 - The field of cysteinyl leukotriene research has moved forward considerably in the past two years. Significant recent advances have been made in three areas: genetic control of the cysteinyl leukotriene response, in which alterations in both the promoter region and in transcribed mRNA have been described; the mechanisms by which cysteinyl leukotrienes promote the development of inflammation; and extensions in the clinical arena that support broader positioning of leukotriene modifiers in the therapy of asthma and allergic diseases.

AB - The field of cysteinyl leukotriene research has moved forward considerably in the past two years. Significant recent advances have been made in three areas: genetic control of the cysteinyl leukotriene response, in which alterations in both the promoter region and in transcribed mRNA have been described; the mechanisms by which cysteinyl leukotrienes promote the development of inflammation; and extensions in the clinical arena that support broader positioning of leukotriene modifiers in the therapy of asthma and allergic diseases.

KW - Cysteinyl leukotrienes

KW - Eosinophils

KW - Genetics

KW - Immunology

KW - Leukotriene modifiers

KW - Molecular Medicine

KW - Pharmacology

UR - http://www.scopus.com/inward/record.url?scp=0035376519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035376519&partnerID=8YFLogxK

U2 - 10.1016/S1471-4892(01)00041-8

DO - 10.1016/S1471-4892(01)00041-8

M3 - Article

VL - 1

SP - 230

EP - 234

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

IS - 3

ER -